The publications from these studies raised substantial awareness in clinicians for the potential role of CACNA1D missense variants as a cause for a neurodevelopmental disorder with or without endocrine symptoms and allowed to identify other mutations (L271H, A749T) in three additional individuals within this disease spectrum (22,28,29). This evidence concerns the gene CACNA1D and neurodevelopmental disorder.